These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33400927)

  • 1. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
    Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
    Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
    Oliveira SC; de Magalhães MTQ; Homan EJ
    Front Immunol; 2020; 11():587615. PubMed ID: 33193414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Almofti YA; Abd-Elrahman KA; Eltilib EEM
    BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling.
    Kutlutürk I; Tokuç EÖ; Karabaş L; Rückert R; Kaya M; Karagöz A; Munk MR
    Immunol Res; 2024 Feb; 72(1):50-71. PubMed ID: 37642808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms.
    O'Donoghue SI; Schafferhans A; Sikta N; Stolte C; Kaur S; Ho BK; Anderson S; Procter JB; Dallago C; Bordin N; Adcock M; Rost B
    Mol Syst Biol; 2021 Sep; 17(9):e10079. PubMed ID: 34519429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
    Bianchi M; Benvenuto D; Giovanetti M; Angeletti S; Ciccozzi M; Pascarella S
    Biomed Res Int; 2020; 2020():4389089. PubMed ID: 32596311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
    Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
    Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study on non-synonymous mutational patterns in structural proteins of SARS-CoV-2.
    Das JK; Roy S
    Genome; 2021 Jul; 64(7):665-678. PubMed ID: 33788636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction of the epitopes of SARS-CoV-2 by immunoinformatics].
    Zhao J; Mao Y; Dong R; Tong X; Zhang Q; Zha Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jun; 37(6):487-494. PubMed ID: 34060442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses.
    Tilocca B; Soggiu A; Sanguinetti M; Musella V; Britti D; Bonizzi L; Urbani A; Roncada P
    Microbes Infect; 2020; 22(4-5):188-194. PubMed ID: 32302675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunodominant and neutralization linear epitopes for SARS-CoV-2.
    Lu S; Xie XX; Zhao L; Wang B; Zhu J; Yang TR; Yang GW; Ji M; Lv CP; Xue J; Dai EH; Fu XM; Liu DQ; Zhang L; Hou SJ; Yu XL; Wang YL; Gao HX; Shi XH; Ke CW; Ke BX; Jiang CG; Liu RT
    Cell Rep; 2021 Jan; 34(4):108666. PubMed ID: 33503420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.
    Dai Y; Chen H; Zhuang S; Feng X; Fang Y; Tang H; Dai R; Tang L; Liu J; Ma T; Zhong G
    Pathog Glob Health; 2020 Dec; 114(8):463-470. PubMed ID: 33198594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
    Xu W; Wang M; Yu D; Zhang X
    Front Immunol; 2020; 11():565278. PubMed ID: 33013929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
    Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
    Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.